Fig. 7
CSF Biomarkers Percent Changes from Baseline. Biomarkers in the CSF, measured at Baseline, at Week 11 (1 week after the last treatment infusion), and at the end of the study (Week 22, or early termination), expressed as a percentage of baseline values. Dotted lines are subjects in Cohort 1 (1 × 109 cells), dashed lines are subjects in Cohort 2 (2 × 109 cells) and solid lines are subjects in Cohort 3 (4 × 109 cells). Subject 12 did not complete the Week 22 assessment